Access cutting-edge early psychosis treatment through this clinical trial at a research site in San Diego. Study-provided care at no cost to qualified participants.
Access early psychosis specialists in San Diego at no cost
This study follows strict safety protocols and ethical guidelines
All study-related early psychosis treatment provided free
This is an outpatient, single center, between-group, double blind, placebo controlled design. Approximately 120 adolescents and adult patients will be randomized to either have their treatment augmented with Cannabidiol Oral Solution (CBD) or with a matching CBD placebo for 8 weeks. The study will examine CBD as an augmentation strategy in early psychosis. It is hypothesized that CBD will improve symptoms, neurocognition, markers of inflammation and eating behaviors. Importantly, moderators and
Sponsor: University of California, San Diego
Check if you qualify for this early psychosis clinical trial in San Diego, CA
If you're searching for early psychosis treatment options in San Diego, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Diego research site is actively enrolling participants for this clinical trial. You'll receive care from experienced early psychosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.